Aavis Pharmaceuticals
is a Private company. Dhananjay Barot is the CEO of Aavis Pharmaceuticals and has an approval rating of 90 from Owler members. Aavis Pharmaceuticals's top competitor is Morningside, led by Tim Brady, who is their CEO. Aavis Pharmaceuticals has 2 followers on Owler.Aavis Pharmaceuticals
is a Private company. Dhananjay Barot is the CEO of Aavis Pharmaceuticals and has an approval rating of 90 from Owler members. Aavis Pharmaceuticals's top competitor is Morningside, led by Tim Brady, who is their CEO. Aavis Pharmaceuticals has 2 followers on Owler.
News
Mar 12, 2025
Business Standard
Aavis Pharmaceuticals: Senores Pharma up 4% as board approves acquisition of 3.73% stake in Havix
Nov 06, 2020
BW BUSINESSWORLD
Aavis Pharmaceuticals: Jubilant Pharma Ltd. and Aavis Pharmaceuticals launch Hydroxychloroquine Sulfate tablets in the U.S. market
Feb 26, 2019
The Hindu Business Line
Aavis Pharmaceuticals: Aavis Pharma gets FDA clearance for US plant
